Radium 223 is under investigation in clinical trial NCT02463799 (Ph 2 Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC). It is grouped under the following drug class(es): Radiopharmaceuticals. The directory classifies it as a commercial API with a mineral/inorganic source/manufacturing origin. Other names for this substance include Radium Ra-223 and 223Ra radioisotope. Its PubChem CID is 6335825.
Radium-223
| CAS No | 15623-45-7 |
|---|---|
| Molecular Formula | Ra |
| Molecular Weight | 223.01850 g/mol |
| Synonyms | radium-223 |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Radium 223 is under investigation in clinical trial NCT02463799 (Ph 2 Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC).
The listed CAS number is 15623-45-7.
The listed molecular formula is Ra.
The listed molecular weight is 223.01850 g/mol.
radium-223.
The source lists Radium Ra-223 and 223Ra radioisotope.